In today’s competitive marketplace, proving a product’s efficacy is an important way for manufacturers to set themselves apart from rivals, and double-blind placebo-controlled trials is one of the best ways of doing so.
The proposed £7bn (€10.2bn) merger of Boots with Alliance UniChem
merger took another step towards completion with announcements for
the dates for both companies Extraordinary General Meetings (EGM)
to vote on the resolutions to create...
